Cargando…
Development of a dual hybrid AAV vector for endothelial-targeted expression of von Willebrand factor
Von Willebrand disease (VWD), the most common inherited bleeding disorder in humans, is caused by quantitative or qualitative defects in von Willebrand factor (VWF). VWD represents a potential target for gene therapy applications, as a single treatment could potentially result in a long-term correct...
Autores principales: | Barbon, Elena, Kawecki, Charlotte, Marmier, Solenne, Sakkal, Aboud, Collaud, Fanny, Charles, Severine, Ronzitti, Giuseppe, Casari, Caterina, Christophe, Olivier D., Denis, Cécile V., Lenting, Peter J., Mingozzi, Federico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113149/ https://www.ncbi.nlm.nih.gov/pubmed/33456057 http://dx.doi.org/10.1038/s41434-020-00218-6 |
Ejemplares similares
-
Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors
por: Barbon, Elena, et al.
Publicado: (2020) -
Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
por: Fitzpatrick, Zachary, et al.
Publicado: (2018) -
Von Willebrand Factor Abnormalities Studied in the Mouse Model: What We Learned about VWF Functions
por: Casari, Caterina, et al.
Publicado: (2013) -
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
por: Meliani, Amine, et al.
Publicado: (2018) -
In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor
por: Badirou, Idinath, et al.
Publicado: (2012)